A plant called Oldenlandia affinis has been used to develop a drug that can slow down the progression of multiple sclerosis.
A drug extracted from the medicinal plant Oldenlandia affinis can block the progression of multiple sclerosis (MS) and was successful in animal models, according to findings published in the journal PNAS.
An international team of researchers developed the oral drug named T20K from the O. affinis plant extract. More specifically, the drug comes from a synthesized plant peptide from the cyclotide drug class. The researchers reported success in an animal model – normal clinical MS symptoms were stopped – and added that there are patent applications filed in several countries.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases,” University of Queensland researcher Christian Gruber, PhD, explained in a press release. “Cyxone’s immediate focus is on bringing T20K through the pre clinical program required for delivering a safe, orally active drug.”
|Read Full Article: Plant Extract Effective Against Multiple Sclerosis Progression in Animal Models|